Business / Finance

RSS

Artimplant reports net revenue of SEK 9.7 million for January – June, 2011

Artimplant: First six months: Net revenue amounted to SEK 9.7 million.

3 Aug 2011

SFS completes $5.7M financing for new outpatient surgery center

Siemens Financial Services, Inc., the U.S. unit of Siemens' Financial Services division, recently completed a $5.7 million financing to support the development of a new outpatient surgery center, doing business as the Surgery Center of Anchorage located in Anchorage, Alaska.

3 Aug 2011

MSMB offers $18 per share for Amag acquisition

MSMB Capital Management today announced that it has made a proposal to the Board of Directors of Amag Pharmaceuticals Inc. to acquire all of the outstanding shares of common stock of Amag for $18 per share in cash or an aggregate of $378 million.

3 Aug 2011

Akorn enters agreement to acquire minority ownership in Aciex

Akorn, Inc., a niche specialty pharmaceutical company, today announced that it has entered into an agreement to acquire a minority ownership in Westborough, MA, based Aciex Therapeutics Inc., an ophthalmic drug development company with a focus on developing novel therapeutics to treat ocular diseases.

3 Aug 2011

BioSante closes underwritten public offering of common stock

BioSante Pharmaceuticals, Inc. today announced the closing of its underwritten public offering of 16.0 million shares of common stock at a public offering price of $3.00 per share, for total gross proceeds of $48.0 million before underwriting discounts and commissions.

3 Aug 2011

Pfizer second-quarter revenues decrease 1% to $17.0 billion

Pfizer Inc. today reported financial results for second-quarter 2011. As a result of Pfizer's decision to sell the Capsugel business, all revenues and expenses related to Capsugel in all periods presented are reflected in a single line, Discontinued operations - net of tax.

3 Aug 2011

AtriCure second quarter revenue increases 18.2% to $16.8 million

AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, today announced financial results for the second quarter of 2011. Revenue was $16.8 million, reflecting 18.2 percent growth over the second quarter of 2010.

2 Aug 2011

Exact Sciences second quarter total revenues decreases to $1.0 million

Exact Sciences Corp. today announced its financial results for the quarter ended June 30, 2011.

2 Aug 2011

IASIS Healthcare third quarter net revenue increases 12.6% to $718.6 million

IASIS Healthcare LLC today announced financial and operating results for the fiscal third quarter and nine months ended June 30, 2011.

2 Aug 2011

ARIAD reports $47.8 million net loss for second quarter 2011

ARIAD Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2010 and provided an update on corporate developments.

2 Aug 2011

Amedisys second quarter net service revenue decreases 11.5% to $373.7 million

Amedisys, Inc., a leading home health and hospice company, today reported its financial results for the three and six-month periods ended June 30, 2011 and lowered 2011 guidance.

2 Aug 2011

Rigel reports net loss of $21.5 million for second quarter 2011

Rigel Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2011.

2 Aug 2011

Akorn second quarter revenue grows 59% to $32.1 million

Akorn, Inc., a niche specialty pharmaceutical company, today reported financial results for the second quarter of 2011. The Company also separately announced that it has entered into an agreement to acquire a minority ownership in Westborough, MA, based Aciex Therapeutics Inc., an ophthalmic drug development company with a focus on developing novel therapeutics to treat front-of-eye diseases.

2 Aug 2011

STERIS first quarter revenue increases to $318.6 million

STERIS Corporation today announced financial results for its fiscal 2012 first quarter ended June 30, 2011. As reported, fiscal 2012 first quarter revenue was $318.6 million compared with $189.0 million in the first quarter of fiscal 2011.

2 Aug 2011

Henry Schein second quarter net sales increase 15.2% to $2.1 billion

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended June 25, 2011.

2 Aug 2011

Tenet second quarter net operating revenues increase 3.1% to $2.374 billion

Tenet Healthcare Corporation today reported adjusted EBITDA of $277 million for the second quarter ended June 30, 2011, an increase of $9 million, or 3.4 percent, compared to $268 million for the second quarter of 2010. Income from continuing operations, before income taxes, was $66 million in the second quarter of 2011, an increase of $1 million, or 1.5 percent, as compared to $65 million in the second quarter of 2010.

2 Aug 2011

Compugen second quarter net income increases to $1.2 million

Compugen Ltd. today reported its results for the second quarter ending June 30, 2011.

2 Aug 2011

Nu Skin Enterprises second-quarter revenue increases 9% to $424.4 million

Nu Skin Enterprises, Inc. today announced record second-quarter results, with revenue of $424.4 million, a 9 percent improvement over the prior-year period.

2 Aug 2011

MEDNAX second quarter net income increases 13.3% to $55.9 million

MEDNAX, Inc., the national medical group specializing in neonatal, maternal-fetal, pediatric cardiology, other pediatric subspecialty and anesthesia physician services today reported earnings per share of $1.15 for the three months ended June 30, 2011.

2 Aug 2011

BD third quarter revenues increase to $2.014 billion

BD, a leading global medical technology company, today reported quarterly revenues of $2.014 billion for the third fiscal quarter ended June 30, 2011, representing an increase of 10.0 percent from the prior-year period.

From BD (Becton, Dickinson and Company) 2 Aug 2011